Project: Determining the role of clinical and epigenetic risk markers in dilated cardiomyopathies and heart failure
| Acronym | DETECTIN-HF (Reference Number: 7. JTC-2016_122) |
| Duration | 01/09/2017 - 31/08/2020 |
| Project Topic | Dilated cardiomyopathy is a major cause of heart failure and is the main indication of cardiac transplantation. About 30-50% of the cases can be explained by genetic predisposition. However, the precise mechanisms that lead to variations in disease susceptibility and phenotype presentation including risk for heart failure or sudden cardiac death are thus far unknown. The DETECTIN-HF project will work with selected clinical and molecular markers in a multi-center, multi-national cohort. The facility which arises by creating this single, harmonized portal is unique in setup and scale and is invaluable for research and improved clinical practice. |
| Network | ERA-CVD |
| Call | ERA-CVD Joint Transnational Call 2016 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | University Hospital Heidelberg | Coordinator | Germany |
| 2 | University Medical Center Utrecht | Partner | Netherlands |
| 3 | University Hospital Ambroise Paré & Pitié-Salpêtrière | Partner | France |
| 4 | University of Tartu | Partner | Estonia |
| 5 | Institute of Cardiology | Partner | Poland |